-+ 0.00%
-+ 0.00%
-+ 0.00%

PolyPeptide Elects John Chongbo Rim Chairman, Effective Upon Samsung Takeover Completion

PUBT·10/26/2026 18:10:55
Listen to the news
PolyPeptide Elects John Chongbo Rim Chairman, Effective Upon Samsung Takeover Completion
  • PolyPeptide shareholders elected John Chongbo Rim as board chair at an extraordinary general meeting on October 26, 2026.
  • Seungho Ryu, Cheol Woo Ryu, Mihyun Yang and Joonkyung Seong were also elected to the board.
  • Cheol Woo Ryu and Seungho Ryu were additionally elected to a board committee.
  • All appointments are conditional on completion of Samsung Peptide's public takeover offer and take effect at closing.
  • Samsung Peptide is wholly owned by Samsung Biologics. All elected terms run until the conclusion of the next annual general meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPeptide Group AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2422544_de) on October 26, 2026, and is solely responsible for the information contained therein.